Chief commercial officer Hopman sells $7,015 of Beta Bionics stock
Related news
-
Europe markets gain as softer oil and yields offset geopolitical risks
-
Why is Nexans stock climbing today?
-
Why is Vallourec stock rallying today?
-
JPMorgan downgrades Enact Holdings stock rating on valuation
-
Stellantis, Renault gain as EU, China agree to curb Chinese hybrid car exports
-
Oil falls, CPI and bank earnings in focus - what’s moving markets
-
Volkswagen deliveries post steepest drop in more than four years as China weakness deepens
-
Intel CEO says Chinese frontier AI model adoption has been ’very fast’